Exelixis
EXEL
#1553
Rank
S$18.55 B
Marketcap
S$74.88
Share price
1.03%
Change (1 day)
56.37%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company